Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 425

    1.

    Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo.

    Spandau UH, Sauder G, Schubert U, Hammes HP, Jonas JB.

    Br J Ophthalmol. 2005 Jun;89(6):745-7.PMID: 15923512 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Impact of triamcinolone acetonide on retinal endothelial cells in a retinopathy of prematurity mouse model.

    Akkoyun I, Yilmaz G, Oto S, Kahraman B, Haberal N, Akova YA.

    Acta Ophthalmol Scand. 2007 Nov;85(7):791-4. Epub 2007 May 4.PMID: 17488319 [PubMed - indexed for MEDLINE]Related articles

    3.

    Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy.

    Hartnett ME, Martiniuk DJ, Saito Y, Geisen P, Peterson LJ, McColm JR.

    Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4975-82.PMID: 17065516 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.

    McCollum GW, Rajaratnam VS, Bullard LE, Yang R, Penn JS.

    Exp Eye Res. 2004 May;78(5):987-95.PMID: 15051479 [PubMed - indexed for MEDLINE]Related articles

    5.

    Influence of triamcinolone intravitreal injection on retinochoroidal healing processes.

    Dot C, Behar-Cohen F, BenEzra D, Doat M, Jonet L, May F, Jeanny JC.

    Exp Eye Res. 2007 Jun;84(6):1081-9. Epub 2007 Feb 11.PMID: 17408616 [PubMed - indexed for MEDLINE]Related articles

    6.

    Recombinant alpha2(IV)NC1 domain of type IV collagen is an effective regulator of retinal capillary endothelial cell proliferation and inhibits pre-retinal neovascularisation.

    Coleman G, Gardiner TA, Boutaud A, Stitt AW.

    Graefes Arch Clin Exp Ophthalmol. 2007 Apr;245(4):581-7. Epub 2006 Aug 17.PMID: 16915401 [PubMed - indexed for MEDLINE]Related articles

    7.

    Expression of thrombospondin-1 in ischemia-induced retinal neovascularization.

    Suzuma K, Takagi H, Otani A, Oh H, Honda Y.

    Am J Pathol. 1999 Feb;154(2):343-54.PMID: 10027393 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Deguelin inhibits retinal neovascularization by down-regulation of HIF-1alpha in oxygen-induced retinopathy.

    Kim JH, Kim JH, Yu YS, Shin JY, Lee HY, Kim KW.

    J Cell Mol Med. 2008 Dec;12(6A):2407-15.PMID: 18208562 [PubMed - indexed for MEDLINE]Related articles

    9.

    The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.

    Neu J, Afzal A, Pan H, Gallego E, Li N, Li Calzi S, Caballero S, Spoerri PE, Shaw LC, Grant MB.

    Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3151-5.PMID: 16799062 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Riluzole inhibits VEGF-induced endothelial cell proliferation in vitro and hyperoxia-induced abnormal vessel formation in vivo.

    Yoo MH, Hyun HJ, Koh JY, Yoon YH.

    Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4780-7.PMID: 16303979 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.

    Rauniyar RK, Suzuma K, King AL, Aiello LP, King GL.

    Invest Ophthalmol Vis Sci. 2002 Feb;43(2):503-9.PMID: 11818397 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Calcitriol is a potent inhibitor of retinal neovascularization.

    Albert DM, Scheef EA, Wang S, Mehraein F, Darjatmoko SR, Sorenson CM, Sheibani N.

    Invest Ophthalmol Vis Sci. 2007 May;48(5):2327-34.PMID: 17460298 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.

    Banin E, Dorrell MI, Aguilar E, Ritter MR, Aderman CM, Smith AC, Friedlander J, Friedlander M.

    Invest Ophthalmol Vis Sci. 2006 May;47(5):2125-34.PMID: 16639024 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide.

    Danis RP, Bingaman DP, Yang Y, Ladd B.

    Ophthalmology. 1996 Dec;103(12):2099-104.PMID: 9003344 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of intravitreal triamcinolone acetonide on retinal apoptosis in experimental retinal neovascularization.

    Spandau UH, Vom Hagen F, Hammes HP, Jonas JB.

    Graefes Arch Clin Exp Ophthalmol. 2008 Jul;246(7):1069-70. Epub 2008 Apr 17. No abstract available. PMID: 18418624 [PubMed - indexed for MEDLINE]Related articles

    16.

    Vascular endothelial growth factor upregulates expression of ADAMTS1 in endothelial cells through protein kinase C signaling.

    Xu Z, Yu Y, Duh EJ.

    Invest Ophthalmol Vis Sci. 2006 Sep;47(9):4059-66.PMID: 16936124 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy.

    Higgins RD, Yu K, Sanders RJ, Nandgaonkar BN, Rotschild T, Rifkin DB.

    Curr Eye Res. 1999 Jan;18(1):20-7.PMID: 10075199 [PubMed - indexed for MEDLINE]Related articles

    18.

    Dexamethasone and critical effect of timing on retinopathy.

    Yossuck P, Yan Y, Tadesse M, Higgins RD.

    Invest Ophthalmol Vis Sci. 2000 Sep;41(10):3095-9.PMID: 10967069 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.

    Zamora DO, Davies MH, Planck SR, Rosenbaum JT, Powers MR.

    Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2175-82.PMID: 15914639 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Experimental retinopathy of prematurity: angiostatic inhibition by nimodipine, ginkgo-biloba, and dipyridamole, and response to different growth factors.

    Juárez CP, Muiño JC, Guglielmone H, Sambuelli R, Echenique JR, Hernández M, Luna JD.

    Eur J Ophthalmol. 2000 Jan-Mar;10(1):51-9.PMID: 10744206 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data